Schizophrenia and the serotonin transporter gene

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Schizophrenia is a complex psychiatric disorder with a significant genetic component.
• Serotonin transporter (5-HTT) and serotonin 5-HT2a receptor (HTR2) genes are implicated in neurotransmitter regulation and psychiatric conditions.

Purpose of the Study:

• To investigate the association between bi-allelic polymorphisms in the 5-HTT and HTR2 genes and schizophrenia.
• To explore potential correlations with clinical factors such as age at onset, familiality, and medication response.

Main Methods:

• A case-control study design was employed, comparing individuals diagnosed with schizophrenia (DSM IV criteria) against screened adult controls.
• Genotyping for polymorphisms in the promoter region of the 5-HTT gene and the HTR2 gene was performed across three distinct cohorts: US Caucasians, African-Americans, and Swedish Caucasians.

Main Results:

• No significant association was found between 5-HTT polymorphisms and schizophrenia in any of the studied cohorts (US Caucasians, African-Americans, Swedish Caucasians).
• Survival analysis indicated a tentative association between 5-HTT polymorphisms and age at onset in the Swedish schizophrenia cohort, though this was not replicated in US samples.
• Exploratory analyses did not reveal significant associations with schizophrenia subgroups based on familiality, medication response, or joint effects of 5-HTT and HTR2 genotypes.

Conclusions:

• The study did not find a direct association between 5-HTT gene polymorphisms and schizophrenia across diverse populations.
• A potential, albeit tentative, link between 5-HTT and age at onset in schizophrenia warrants further investigation in larger, well-defined cohorts.
• The findings suggest that 5-HTT gene variations may not be a primary genetic risk factor for schizophrenia in the studied populations.